Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
519
archived clinical trials in
Bronchitis

24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
805
mi
from
Decatur, GA
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
805
mi
from
Decatur, GA
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
517
mi
from
Albuquerque, NM
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
517
mi
from
Albuquerque, NM
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
155
mi
from
Oklahoma City, OK
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
155
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
1206
mi
from
Phoenixville, PA
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
1206
mi
from
Phoenixville, PA
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
916
mi
from
Gaffney, SC
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
916
mi
from
Gaffney, SC
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
883
mi
from
Greenville, SC
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
883
mi
from
Greenville, SC
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
953
mi
from
Rock Hill, SC
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
953
mi
from
Rock Hill, SC
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
854
mi
from
Seneca, SC
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
854
mi
from
Seneca, SC
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
520
mi
from
Rapid City, SD
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
520
mi
from
Rapid City, SD
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
561
mi
from
San Antonio, TX
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
561
mi
from
San Antonio, TX
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
1167
mi
from
Newport News, VA
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
1167
mi
from
Newport News, VA
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
1113
mi
from
Richmond, VA
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
1113
mi
from
Richmond, VA
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Clermont Ferrand cedex 1,
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Clermont Ferrand cedex 1,
Click here to add this to my saved trials
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
404
mi
from
Saint Charles, MO
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
A Multicenter Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GW642444 and With Tiotropium Over 24 Weeks in Subjects With COPD
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
404
mi
from
Saint Charles, MO
Click here to add this to my saved trials
Transpyloric Feeding in Severe Bronchopulmonary Dysplasia
Pilot N-of-1 Multiple Crossover Randomized Trial of Gastric and Transpyloric Feeds in Infants With Severe Bronchopulmonary Dysplasia
Status: Enrolling
Updated:  2/2/2018
Children's Hospital of Philadelphia
1225
mi
from
Philadelphia, PA
Transpyloric Feeding in Severe Bronchopulmonary Dysplasia
Pilot N-of-1 Multiple Crossover Randomized Trial of Gastric and Transpyloric Feeds in Infants With Severe Bronchopulmonary Dysplasia
Status: Enrolling
Updated: 2/2/2018
Children's Hospital of Philadelphia
1225
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant Recipients
A Pilot Study to Demonstrate Efficacy and Safety of Aerosol Liposomal Cyclosporine (L-CsA) in the Treatment of Bronchiolitis Obliterans Syndrome After Lung Transplantation
Status: Enrolling
Updated:  3/1/2018
University of Maryland Medical Center
1148
mi
from
Baltimore, MD
Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant Recipients
A Pilot Study to Demonstrate Efficacy and Safety of Aerosol Liposomal Cyclosporine (L-CsA) in the Treatment of Bronchiolitis Obliterans Syndrome After Lung Transplantation
Status: Enrolling
Updated: 3/1/2018
University of Maryland Medical Center
1148
mi
from
Baltimore, MD
Click here to add this to my saved trials
Montelukast to Treat Bronchiolitis Obliterans
Multi-Institutional Prospective Phase II Study of Montelukast for the Treatment of Bronchiolitis Obliterans Following Allogeneic or Autologous Stem Cell Transplantation in Children and Adults
Status: Enrolling
Updated:  4/6/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Montelukast to Treat Bronchiolitis Obliterans
Multi-Institutional Prospective Phase II Study of Montelukast for the Treatment of Bronchiolitis Obliterans Following Allogeneic or Autologous Stem Cell Transplantation in Children and Adults
Status: Enrolling
Updated: 4/6/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease
Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease
Status: Enrolling
Updated:  4/18/2018
National Jewish Health
407
mi
from
Denver, CO
Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease
Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease
Status: Enrolling
Updated: 4/18/2018
National Jewish Health
407
mi
from
Denver, CO
Click here to add this to my saved trials
The Natural History of Gene Expression in the Lung Cells of Non-Smokers, Smokers and Ex-Smokers in Health and Disease
The Natural History of Gene Expression in Lung Cells of Non-Smokers, Smokers, and Ex-Smokers in Health and Disease
Status: Enrolling
Updated:  4/30/2018
Weill Cornell Medical College and Weill Cornell Medical Center, Department of Genetic Medicine
1286
mi
from
New York, NY
The Natural History of Gene Expression in the Lung Cells of Non-Smokers, Smokers and Ex-Smokers in Health and Disease
The Natural History of Gene Expression in Lung Cells of Non-Smokers, Smokers, and Ex-Smokers in Health and Disease
Status: Enrolling
Updated: 4/30/2018
Weill Cornell Medical College and Weill Cornell Medical Center, Department of Genetic Medicine
1286
mi
from
New York, NY
Click here to add this to my saved trials